The primary objective of this Non- Interventional Study (NIS) is to describe the use of atypical antipsychotics in subjects with Schizophrenia during the hospitalisation due to acute psychotic episode by evaluation of drug, dose and mode of administration of the medication.
RECONNECT-S BETA
Study Type
OBSERVATIONAL
Enrollment
1,076
Research Site
Cairo, Egypt
Research Site
Dammam, Saudi Arabia
Research Site
Jeddah, Saudi Arabia
Research Site
Riyadh, Saudi Arabia
Use of atypical antipsychotic(s) during hospitalisation.
The data will be collected at one visit at the moment of discharge from the hospital.
Time frame: Hospitalisation period, an expected average of 3 weeks (variable per patient).
Daily dosage of atypical antipsychotic(s) during hospitalisation.
The data will be collected at one visit at the moment of discharge from the hospital.
Time frame: Hospitalisation period, an expected average of 3 weeks (variable per patient).
Mode of administration of atypical antipsychotic(s) during hospitalisation.
The data will be collected at one visit at the moment of discharge from the hospital.
Time frame: Hospitalisation period, an expected average of 3 weeks (variable per patient).
Percent of patients with atypical antipsychotic as monotherapy.
The data will be collected at one visit at the moment of discharge from the hospital.
Time frame: Hospitalisation period, an expected average of 3 weeks (variable per patient).
Percent of patients with combinations of antipsychotics.
The data will be collected at one visit at the moment of discharge from the hospital.
Time frame: Hospitalisation period, an expected average of 3 weeks (variable per patient).
Main criteria of an antipsychotic's selection during hospitalisation expressed as percentage.
The data will be collected at one visit at the moment of discharge from the hospital.
Time frame: Hospitalisation period, an expected average of 3 weeks (variable per patient).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Abu Dhabi, United Arab Emirates
Research Site
Dubai, United Arab Emirates
Research Site
Ras al-Khaimah, United Arab Emirates
Use of psychometric scales in day to day practice in therm of evaluation of the disease symptoms and thus efficacy of the treatment.
The data will be collected at one visit at the moment of discharge from the hospital.
Time frame: Hospitalisation period, an expected average of 3 weeks (variable per patient).
Description of the usage of concomitant psychiatric medication (other than atypical antipsychotic) during the hospitalization.
The data will be collected at one visit at the moment of discharge from the hospital.
Time frame: Hospitalisation period, an expected average of 3 weeks (variable per patient).
Relationship between medication used during the hospitalization and maintenance therapy recommended upon discharge.
The data will be collected at one visit at the moment of discharge from the hospital.
Time frame: Hospitalisation period, an expected average of 3 weeks (variable per patient).